PDCD4 gene silencing in gliomas is associated with 5'CpG island methylation and unfavourable prognosis.
Programmed cell death 4 (PDCD4) is a newly described tumour suppressor that inhibits oncogenesis by suppressing gene transcription and translation. Loss of PDCD4 expression has been found in several types of human cancers including the most common cancer of the brain, the gliomas. However, the molecular mechanisms responsible for PDCD4 gene silencing in tumour cells remain unclear. Here we report the identification of 5'CpG island methylation as the predominant cause of PDCD4 mRNA silencing in gliomas. The methylation of the PDCD4 5'CpG island was found in 47% (14/30) of glioma tissues, which was significantly associated with the loss of PDCD4 mRNA expression (gamma=-1.000, P < 0.0001). Blocking methylation in glioma cells using a DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, restored the PDCD4 gene expression, inhibited their proliferation and reduced their colony formation capacity. Longitudinal studies of a cohort of 84 patients with gliomas revealed that poor prognosis of patients with high-grade tumours were significantly associated with loss of PDCD4 expression. Thus, our current study suggests, for the first time, that PDCD4 5'CpG island methylation blocks PDCD4 expression at mRNA levels in gliomas. These results also indicate that PDCD4 reactivation might be an effective new strategy for the treatment of gliomas.
Gao
Fei
F
Department of Immunology, School of Medicine, Shandong University, Jinan, Shandong, China.
Wang
Xiaoyan
X
Zhu
Faliang
F
Wang
Qun
Q
Zhang
Xia
X
Guo
Chun
C
Zhou
Chengjun
C
Ma
Chunhong
C
Sun
Wensheng
W
Zhang
Yun
Y
Chen
Youhai H
YH
Zhang
Lining
L
D000328:Adult; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins / Q000235:genetics* / Q000378:metabolism; D001483:Base Sequence; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D018899:CpG Islands / Q000235:genetics*; D019175:DNA Methylation / Q000235:genetics*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D020868:Gene Silencing; D005910:Glioma / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism; D016019:Survival Analysis; D014410:Tumor Stem Cell Assay
D051017:Apoptosis Regulatory Proteins; C114487:PDCD4 protein, human; D012333:RNA, Messenger; D016601:RNA-Binding Proteins
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14037-42
10570194
Oncogene. 2004 Oct 21;23(49):8135-45
15361828
Mol Cancer Ther. 2006 Apr;5(4):1041-9
16648576
J Neurosurg. 2000 Dec;93(6):932-9
11117865
J Korean Med Sci. 2000 Oct;15(5):555-9
11068994
Nat Med. 1995 Jul;1(7):686-92
7585152
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Oct;27(5):597-600
16274040
Eur J Gastroenterol Hepatol. 2007 Nov;19(11):952-61
18049164
J Biol Chem. 2008 Jan 11;283(2):1026-33
17991735
Technol Cancer Res Treat. 2006 Jun;5(3):185-94
16700615
J Pathol. 2003 Aug;200(5):640-6
12898601
Oncogene. 2008 Mar 6;27(11):1527-35
17828298
Mol Cell Biochem. 2002 May-Jun;234-235(1-2):185-93
12162432
Gene. 1995 Dec 12;166(2):297-301
8543179
Oncogene. 2004 Sep 30;23(45):7484-93
15334056
Bioinformatics. 2002 Nov;18(11):1427-31
12424112
Oncogene. 2002 Aug 12;21(35):5400-13
12154403
Science. 2006 Oct 20;314(5798):467-71
17053147
J Immunol. 2006 Dec 1;177(11):8095-102
17114484
Cancer Res. 2004 Oct 1;64(19):6892-9
15466178
Trends Genet. 2000 Apr;16(4):168-74
10729832
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6
8790415
Oncogene. 2008 Apr 3;27(15):2128-36
17968323
Mol Cancer Ther. 2004 Feb;3(2):103-10
14985450
Biochem Biophys Res Commun. 2002 Sep 13;297(1):78-82
12220511
Cancer Res. 2005 Jul 15;65(14):6034-41
16024603
Cancer Res. 2005 Apr 1;65(7):2565-71
15805250
J Microbiol Methods. 2006 Oct;67(1):36-43
16631263
Hum Pathol. 2005 Sep;36(9):1008-15
16153465
Gene Ther. 2007 Sep;14(18):1353-61
17611588
Mol Cell Biol. 2003 Jan;23(1):26-37
12482958
Oncogene. 2006 Oct 5;25(45):6101-12
16682950
Oncogene. 2002 Aug 12;21(35):5427-40
12154405
Mol Cell Biol. 2006 Feb;26(4):1297-306
16449643
Cell Mol Biol (Noisy-le-grand). 1997 Dec;43(8):1227-34
9489949
Acta Neuropathol. 2003 Nov;106(5):479-85
12904991
Oncol Rep. 2007 Jan;17(1):123-8
17143488
Oncogene. 2001 Jan 11;20(2):231-9
11313950
Oncogene. 2003 Jun 12;22(24):3712-20
12802278